Skip to main content
Top
Published in: Diabetologia 4/2007

01-04-2007 | Article

Prevalence and incidence rate of diabetes mellitus in a Swedish community during 30 years of follow-up

Authors: S. P. O. Jansson, D. K. G. Andersson, K. Svärdsudd

Published in: Diabetologia | Issue 4/2007

Login to get access

Abstract

Aims/hypothesis

Increasing diabetes prevalence has been reported in most European countries in the last 20 years. In this study we report on the development of prevalence and incidence of diabetes from 1972 to 2001 in Laxå, a rural community in central Sweden.

Materials and methods

A diabetes register was established at the primary healthcare centre (PHCC) in Laxå, beginning in 1972 and based on data from clinical records at the PHCC, nearby hospitals and private practitioners in the area. In addition, case-finding procedures involving 85% of the residents aged 35 to 79 years old was performed from 1983 onwards.

Results

During the study period a total of 776 new diabetes cases was found, 36 type 1 diabetes mellitus and 740 type 2 diabetes mellitus. The age-standardised incidence rates for type 1 diabetes mellitus and type 2 diabetes mellitus were 0.15 and 3.03 cases per 1,000 population, respectively. No increase in incidence over time was detected for either forms of diabetes. Age-standardised prevalence for women and men increased from 28.3 and 25.9, respectively, per 1,000 in 1972 to 45 and 46.3 per 1,000 in 1988 (p < 0.0001), thereafter falling to a mean of 43.5 per 1,000 for women, while men had a mean of 44.9 per 1,000 for the rest of the study period.

Conclusions/interpretation

The prevalence of diabetes mellitus in Laxå is high, but has not increased during the last 13 years. The incidence rate was relatively stable over the whole 30-year period.
Literature
2.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053PubMed Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053PubMed
3.
4.
go back to reference Andersson DK, Svardsudd K, Tibblin G (1991) Prevalence and incidence of diabetes in a Swedish community 1972–1987. Diabet Med 8:428–434PubMed Andersson DK, Svardsudd K, Tibblin G (1991) Prevalence and incidence of diabetes in a Swedish community 1972–1987. Diabet Med 8:428–434PubMed
5.
go back to reference Berger B, Stenstrom G, Chang YF, Sundkvist G (1998) The prevalence of diabetes in a Swedish population of 280,411 inhabitants. A report from the Skaraborg Diabetes Registry. Diabetes Care 21:546–548PubMed Berger B, Stenstrom G, Chang YF, Sundkvist G (1998) The prevalence of diabetes in a Swedish population of 280,411 inhabitants. A report from the Skaraborg Diabetes Registry. Diabetes Care 21:546–548PubMed
6.
go back to reference Glumer C, Jorgensen T, Borch-Johnsen K (2003) Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 26:2335–2340PubMed Glumer C, Jorgensen T, Borch-Johnsen K (2003) Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 26:2335–2340PubMed
7.
go back to reference Yliharsila H, Lindstrom J, Eriksson JG et al (2005) Prevalence of diabetes and impaired glucose regulation in 45- to 64-year-old individuals in three areas of Finland. Diabet Med 22:88–91PubMedCrossRef Yliharsila H, Lindstrom J, Eriksson JG et al (2005) Prevalence of diabetes and impaired glucose regulation in 45- to 64-year-old individuals in three areas of Finland. Diabet Med 22:88–91PubMedCrossRef
8.
go back to reference Drivsholm T, Ibsen H, Schroll M, Davidsen M, Borch-Johnsen K (2001) Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes. Diabet Med 18:126–132PubMedCrossRef Drivsholm T, Ibsen H, Schroll M, Davidsen M, Borch-Johnsen K (2001) Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes. Diabet Med 18:126–132PubMedCrossRef
9.
go back to reference Midthjell K, Kruger O, Holmen J et al (1999) Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trondelag Health Surveys: 1984–1986 and 1995–1997. Diabetes Care 22:1813–1820PubMed Midthjell K, Kruger O, Holmen J et al (1999) Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trondelag Health Surveys: 1984–1986 and 1995–1997. Diabetes Care 22:1813–1820PubMed
10.
go back to reference Eliasson M, Lindahl B, Lundberg V, Stegmayr B (2002) No increase in the prevalence of known diabetes between 1986 and 1999 in subjects 25–64 years of age in northern Sweden. Diabet Med 19:874–880PubMedCrossRef Eliasson M, Lindahl B, Lundberg V, Stegmayr B (2002) No increase in the prevalence of known diabetes between 1986 and 1999 in subjects 25–64 years of age in northern Sweden. Diabet Med 19:874–880PubMedCrossRef
11.
go back to reference Eliasson M, Boström G (2006) Chapter 5.2: major public health problems—diabetes. Scand J Public Health Suppl 67:59–68PubMedCrossRef Eliasson M, Boström G (2006) Chapter 5.2: major public health problems—diabetes. Scand J Public Health Suppl 67:59–68PubMedCrossRef
12.
go back to reference Andersson DK, Lundblad E, Svardsudd K (1993) A model for early diagnosis of type 2 diabetes mellitus in primary health care. Diabet Med 10:167–173PubMedCrossRef Andersson DK, Lundblad E, Svardsudd K (1993) A model for early diagnosis of type 2 diabetes mellitus in primary health care. Diabet Med 10:167–173PubMedCrossRef
13.
go back to reference World Health Organization (1980) WHO expert committee on diabetes mellitus: second report. World Health Organization Technical Report Series no. 646:1–80 World Health Organization (1980) WHO expert committee on diabetes mellitus: second report. World Health Organization Technical Report Series no. 646:1–80
14.
go back to reference World Health Organization (1985) Diabetes mellitus. Report of a WHO study group. World Health Organization Technical Report Series no. 727:1–113 World Health Organization (1985) Diabetes mellitus. Report of a WHO study group. World Health Organization Technical Report Series no. 727:1–113
15.
go back to reference World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. WHO, Department of Noncommunicable Disease Surveillance, Geneva World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. WHO, Department of Noncommunicable Disease Surveillance, Geneva
16.
go back to reference Colagiuri S, Borch-Johnsen K, Glumer C, Vistisen D (2005) There really is an epidemic of type 2 diabetes. Diabetologia 48:1459–1463PubMedCrossRef Colagiuri S, Borch-Johnsen K, Glumer C, Vistisen D (2005) There really is an epidemic of type 2 diabetes. Diabetologia 48:1459–1463PubMedCrossRef
Metadata
Title
Prevalence and incidence rate of diabetes mellitus in a Swedish community during 30 years of follow-up
Authors
S. P. O. Jansson
D. K. G. Andersson
K. Svärdsudd
Publication date
01-04-2007
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 4/2007
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0593-4

Other articles of this Issue 4/2007

Diabetologia 4/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.